| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |